1h Free Analyst Time
The autoimmune disease diagnostics market is forecasted to grow by USD 3.49 billion during 2024-2029, accelerating at a CAGR of 10.2% during the forecast period. The report on the autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in laboratory automation platforms, discovery of novel biomarkers leading to improved autoimmune disease diagnosis, and increasing mergers and acquisitions activities among market companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The autoimmune disease diagnostics market is segmented as below:
By Type
- Localized diagnostics
- Systemic diagnostics
By Product
- Assay kits
- Analyzer
By End-user
- Clinical laboratories
- Hospitals
- Diagnostic centers
- Research laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the autoimmune disease diagnostics market covers the following areas:
- Autoimmune Disease Diagnostics Market sizing
- Autoimmune Disease Diagnostics Market forecast
- Autoimmune Disease Diagnostics Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Product
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global autoimmune disease diagnostics market: Autoimmune Technologies LLC, Bio RAD Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, Exagen Inc., F. Hoffmann La Roche Ltd., Gold Standard Diagnostics Corp., Grifols SA, Hemagen Diagnostics Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Immco Diagnostics Inc., Laboratory Corp. of America Holdings, Perkin Elmer Inc., Quest Diagnostics Inc., R Biopharm AG, Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is focus on companion diagnostic tests."
According to the report, one of the major drivers for this market is the advancements in laboratory automation platforms.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Autoimmune Technologies LLC
- Bio Rad Laboratories Inc.
- BioMerieux SA
- Danaher Corp.
- DiaSorin SpA
- Exagen Inc.
- F. Hoffmann La Roche Ltd.
- Gold Standard Diagnostics Corp.
- Grifols SA
- Hemagen Diagnostics Inc.
- HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
- Immco Diagnostics Inc.
- Laboratory Corp. of America Holdings
- Perkin Elmer Inc.
- Quest Diagnostics Inc.
- R Biopharm AG
- Siemens AG
- Svar Life Science AB
- Thermo Fisher Scientific Inc.
- Werfenlife SA
